Get the Stockscreener App
0.00
100.00%
-0.2001
Unity Biotechnology Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.
See More
Previous Close:
$0.2001
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$13.94M
Revenue:
-
Net Income/Loss:
$-52.53M
P/E Ratio:
0.00
EPS:
-3.66
Net Cash Flow:
$-39.93M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$3.10
Unity Biotechnology Inc Stock (UBX) Company Profile
Name
Unity Biotechnology Inc
Sector
Industry
Phone
(650) 416-1192
Address
285 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA
Compare UBX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
UBX
Unity Biotechnology Inc
|
0.00 | 13.94M | 0 | -52.53M | -39.93M | -3.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
374.98 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.90 | 60.58B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
418.91 | 54.99B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
674.90 | 42.25B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.23 | 32.93B | 3.81B | -644.79M | -669.77M | -6.24 |
Unity Biotechnology Inc Stock (UBX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-27-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| May-16-25 | Downgrade | Mizuho | Outperform → Neutral |
| Aug-22-24 | Initiated | Rodman & Renshaw | Buy |
| Nov-16-23 | Upgrade | Wedbush | Neutral → Outperform |
| Jan-04-22 | Upgrade | ROTH Capital | Neutral → Buy |
| Nov-10-21 | Upgrade | Mizuho | Neutral → Buy |
| Jun-28-21 | Upgrade | Citigroup | Sell → Buy |
| Jun-07-21 | Initiated | H.C. Wainwright | Buy |
| Feb-16-21 | Downgrade | Citigroup | Neutral → Sell |
| Aug-18-20 | Downgrade | Citigroup | Buy → Neutral |
| Aug-18-20 | Downgrade | Mizuho | Buy → Neutral |
| Aug-18-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-17-20 | Downgrade | ROTH Capital | Buy → Neutral |
| Jul-28-20 | Initiated | ROTH Capital | Buy |
| Dec-12-19 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-07-19 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-07-18 | Initiated | Mizuho | Buy |
| May-29-18 | Initiated | Citigroup | Buy |
| May-29-18 | Initiated | Goldman | Neutral |
| May-29-18 | Initiated | Morgan Stanley | Overweight |
View All
Unity Biotechnology Inc Stock (UBX) Latest News
Trendlines Converge — Decision Point for Unity Biotechnology Inc.Scalable Portfolio Growth Suggestions Released - metal.it
Why is Unity Biotechnology Inc. stock attracting strong analyst attentionAchieve rapid portfolio appreciation - Jammu Links News
Is it the right time to buy Unity Biotechnology Inc. stockAchieve rapid financial growth with expert picks - Jammu Links News
What makes Unity Biotechnology Inc. stock price move sharplyHigh-yield growth strategies - Jammu Links News
When is Unity Biotechnology Inc. stock expected to show significant growthCapitalize on market trends early - Jammu Links News
What is the risk reward ratio of investing in Unity Biotechnology Inc. stockDiscover hidden gems in the stock market - Jammu Links News
Is Unity Biotechnology Inc. a growth stock or a value stockInvest confidently with professional market insights - Jammu Links News
Unity Biotechnology Inc. Stock Analysis and ForecastBuild wealth faster with consistent growth stocks - Jammu Links News
What drives Unity Biotechnology Inc. stock priceFree Real-Time Stock Data - Jammu Links News
What are the latest earnings results for Unity Biotechnology Inc.Free High-Return Strategy Alerts - Jammu Links News
Unity Biotechnology Inc. Stock Flags Risk Zone in Volatility IndexScalable Portfolio Growth Suggestions Released - metal.it
Unity Biotechnology Inc. Breaks Below Key Support LevelOversold Recovery Opportunity Stocks Attract Buyers - metal.it
Unity Biotechnology Inc. Consolidation Zone May Signal AccumulationSwing Trading Entry Signals Suggest Opportunity Zone - metal.it
How to use a screener to detect Unity Biotechnology Inc. breakoutsVolume Based Swing Signal Prediction Map - Newser
How many analysts rate Unity Biotechnology Inc. as a “Buy”Lightning-fast capital gains - jammulinksnews.com
Real time social sentiment graph for Unity Biotechnology Inc. Safe Investment Ideas with Growth Upside - Newser
How does Unity Biotechnology Inc. compare to its industry peersBreakout portfolio performance - jammulinksnews.com
What catalysts could drive Unity Biotechnology Inc. stock higher in 2025Invest smarter with expert stock recommendations - Jammu Links News
Sectors Driving Future Growth for Unity Biotechnology Inc. StockFree Expert-Led Investment Training - Newser
Is Unity Biotechnology Inc. stock overvalued or undervaluedFree Expert Stock Watchlist - Jammu Links News
Published on: 2025-07-25 18:10:37 - Autocar Professional
Why Unity Biotechnology Inc. stock attracts strong analyst attentionHigh Potential Safe Trades - Newser
What analysts say about Unity Biotechnology Inc. stockOverwhelming financial success - PrintWeekIndia
UBX issues 1 share with 600M votes to speed dissolution plan | UBX SEC FilingForm 8-K/A - Stock Titan
Is Unity Biotechnology Inc. a good long term investmentAccelerated wealth building - Autocar Professional
Unity Biotechnology Alters Voting Dynamics with New Stock - TipRanks
How Unity Biotechnology Inc. stock performs during market volatilityFree Stock Movement Tracking - Newser
Unity Biotechnology Inc Stock (UBX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.40%
0.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):